公司资料
Avenue Therapeutics 股价、新闻与催化剂
- 股票代码:
- ATXI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.26 USD (-8.21%)
收盘价
最后更新: 2026年8月14日
—
市值
股价为何变动
Current closing-price context is not available for ATXI.
公司概览
业务概览
Avenue Therapeutics is a specialty pharmaceutical company focused on acute and hospital-based pain management. Its story revolves around trying to bring differentiated pain treatments into controlled clinical settings.
所在地与行业分类
Avenue Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and acute-care pain management.
商业模式特征
The company depends on clinical and regulatory progress, commercial strategy, and the ability to sustain a narrow product focus. Investors track trial updates, development milestones, and capital runway.
生物医药行业定位
Avenue occupies a small acute-pain niche within specialty pharma. The stock tends to move on regulatory news and the market's view of the company’s ability to commercialize in a difficult category.
未来催化剂
- Avenue Therapeutics is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is mainly focused on residual value.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。